Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

1998 • 4,297 citations

The social organization of sexuality: sexual practices in the United States

1995 • 3,042 citations

Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1

2000 • 2,986 citations

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

1997 • 2,670 citations

Recommendations of the Panel on Cost-Effectiveness in Health and Medicine

1996 • 2,447 citations

Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

1997 • 2,097 citations

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 • 1,912 citations

National Hospital Discharge Survey, 1988

1991 • 1,312 citations

Antiretroviral Therapy in Adults

2000 • 1,045 citations

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

1999 • 1,008 citations

Efficacy of Risk-Reduction Counseling to Prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases

1998 • 988 citations

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1999 • 937 citations

Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion

1995 • 922 citations

Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

1999 • 850 citations

A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

1998 • 777 citations

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

1999 • 770 citations

Treatment for Adult HIV Infection

2004 • 749 citations

Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS

1996 • 748 citations

The Beaver Dam Health Outcomes study

1993 • 748 citations

Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy

2001 • 739 citations

A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners

1994 • 669 citations

Principles of economics

1983 • 644 citations

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients

2000 • 553 citations

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease

1998 • 553 citations

The Care of HIV-Infected Adults in the United States

1998 • 537 citations

The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease

2001 • 506 citations

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

2000 • 499 citations

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

1996 • 494 citations

HIV in the United States at the turn of the century: an epidemic in transition

2001 • 480 citations

A Randomized Controlled Trial of an HIV Sexual Risk—Reduction Intervention for Young African-American Women

1995 • 479 citations

Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata

2003 • 447 citations

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1999 • 432 citations

Fat distribution and metabolic changes in patients with HIV infection

1999 • 380 citations

Heterosexual Transmission of Human Immunodeficiency Virus (HIV) in Northern California: Results from a Ten-year Study

1997 • 341 citations

Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study

1996 • 322 citations

Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy

1998 • 318 citations

The NIMH Multisite HIV Prevention Trial: Reducing HIV Sexual Risk Behavior

1998 • 289 citations

Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response

1997 • 283 citations

Expenditures for the Care of HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy

2001 • 272 citations

Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic Failure

1997 • 267 citations

Seroprevalence of HIV and Risk Behaviors Among Young Homosexual and Bisexual Men

1994 • 262 citations

Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy

1998 • 261 citations

Natural History of HIV-1 Cell-Free Viremia

1995 • 249 citations

Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

1998 • 249 citations

Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection

1998 • 243 citations

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

2000 • 240 citations

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1996 • 237 citations

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

1998 • 235 citations

Prognostic Indicators for AIDS and Infectious Disease Death in HIV-Infected Injection Drug Users

1998 • 223 citations

A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients

1998 • 221 citations

HIV-1 Genotypic Resistance Patterns Predict Response to saquinavir–ritonavir Therapy in Patients in Whom Previous Protease Inhibitor Therapy Had Failed

1999 • 219 citations

3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine

2000 • 205 citations

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

1999 • 199 citations

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine

1998 • 189 citations

Predictors of optimal virological response to potent antiretroviral therapy

1999 • 185 citations

Scope of the AIDS Epidemic in the United States

1995 • 179 citations

Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level withRisk of Clinical Progression in Patients with Advanced Infection

1996 • 174 citations

AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function

1997 • 171 citations

On-site, rapid HIV testing with same-day results and counseling

1997 • 168 citations

Failure to Return for HIV Test Results Among Persons at High Risk for HIV Infection

2004 • 166 citations

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

2002 • 166 citations

Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir

1999 • 166 citations

Emergency Department–Based HIV Screening and Counseling: Experience With Rapid and Standard Serologic Testing

1999 • 165 citations

A Meta-Analysis of Utility Estimates for HIV/AIDS

2002 • 156 citations

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

1998 • 155 citations

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

1998 • 143 citations

Change in clinical status, health status, and health utility outcomes in HIV-infected patients.

1995 • 140 citations

Heterosexual Transmission of HIV in Haiti

1996 • 139 citations

The social organization of sexuality : sexual practices in the United States

1994 • 137 citations

Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients

1998 • 132 citations

Feasibility of Human Immunodeficiency Virus Vaccine Trials in Homosexual Men in the United States: Risk Behavior, Seroincidence, and Willingness to Participate

1996 • 128 citations

Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.

1994 • 122 citations

Health Values of Patients Infected with Human Immunodeficiency Virus

1996 • 121 citations

The Will To Live among HIV-Infected Patients

1999 • 120 citations

HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

1997 • 118 citations

A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women

1995 • 118 citations

When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

2001 • 117 citations

Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l

2002 • 114 citations

Cost-utility analyses of clinical preventive services11The full text of this article is available via AJPM Online at http://www.elsevier.com/locate/ajpmonline.

2000 • 113 citations

Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study

2000 • 113 citations

Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches

2000 • 107 citations

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

1996 • 101 citations

Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy

1996 • 95 citations

Human Immunodeficiency Virus 1 Protease Inhibitors in Clinical Practice

1999 • 92 citations

HIV Infection Among Patients in U.S. Acute Care Hospitals

1993 • 91 citations

Orogenital sex and the transmission of HIV among homosexual men

1992 • 91 citations

Natural history of HIV-1 cell-free viremia

1995 • 90 citations

Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants

1999 • 89 citations

HIV-1 RNA levels and the development of clinical disease

1996 • 89 citations

Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial

1999 • 87 citations

Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men. The San Francisco/Berkeley Young Men's Survey

1994 • 86 citations

Antiviral effect of double and triple drug combinations amongst HIV-infected adults

1998 • 86 citations

Role of Viral Load in Heterosexual Transmission of Human Immunodeficiency Virus Type 1 by Blood Transfusion Recipients

1997 • 86 citations

Factors associated with human immunodeficiency virus seroconversion in homosexual men in three San Francisco cohort studies, 1984-1989.

1993 • 86 citations

Multistate Evaluation of Anonymous HIV Testing and Access to Medical Care

1998 • 85 citations

Failure To Return for HIV Posttest Counseling in an STD Clinic Population

2003 • 84 citations

Course of Viral Load Throughout HIV-1 Infection

2000 • 80 citations

Incidence and Predictors of Virologic Failure of Antiretroviral Triple-Drug Therapy in a Community-Based Cohort

1999 • 78 citations

Costs of HIV+/AIDS at CD4+ Counts Disease Stages Based on Treatment Protocols

1996 • 75 citations

Performance Characteristics of Serologic Tests for Human Immunodeficiency Virus Type 1 (HIV-1) Antibody among Minnesota Blood Donors

1989 • 72 citations

Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment

1998 • 71 citations

Disease Progression, Adherence, and Response to Protease Inhibitor Therapy for HIV Infection in an Urban Veterans Affairs Medical Center

1999 • 69 citations

A Critical Assessment of the Prognostic Value of HIV-1 RNA Levels and CD4+ Cell Counts in HIV-Infected Patients

1998 • 69 citations

Feasibility of an Emergency Department–Based, Risk-Targeted Voluntary HIV Screening Program

1996 • 69 citations

Longitudinal HIV-1 RNA Levels in a Cohort of Homosexual Men

1998 • 68 citations

Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency Virus–Infected Cohort

2000 • 67 citations

Risk of Progression to AIDS and Death in Women Infected With HIV-1 Initiating Highly Active Antiretroviral Treatment at Different Stages of Disease

2002 • 67 citations

When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies

2003 • 66 citations

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

1999 • 64 citations

Private sexual behavior, public opinion, and public health policy related to sexually transmitted diseases: a US-British comparison.

1998 • 64 citations

Protease Inhibitor-Based Therapy Is Associated With Decreased HIV-Related Health Care Costs in Men Treated at a Veterans Administration Hospital

1999 • 61 citations

Male homosexual transmission of HIV-1

1994 • 60 citations

Cost-effectiveness of HIV Screening in Acute Care Settings

1996 • 59 citations

Toxicity and drug exposure in a quadruple drug regimen in HIV–1 infected patients participating in the ADAM study

2000 • 58 citations

Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)

1999 • 58 citations

Rapid Communication: Efavirenz- and Adefovir Dipivoxil–Based Salvage Therapy in Highly Treatment-Experienced Patients: Clinical and Genotypic Predictors of Virologic Response

2000 • 57 citations

Performance Characteristics of a Rapid HIV Antibody Assay in a Hospital with a High Prevalence of HIV Infection

1996 • 56 citations

HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors

1998 • 55 citations

The antiviral effect of ritonavir and saquinavir incombination amongst HIV-infected adults

1998 • 54 citations

Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens

1999 • 52 citations

Strategies for Screening Blood for Human Immunodeficiency Virus Antibody

1990 • 51 citations

CD4+ T-Lymphocyte Measures in the Treatment of Individuals Infected With Human Immunodeficiency Virus Type 1

1994 • 50 citations

Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic In Vitro

1998 • 49 citations

Who Should Be Screened for HIV Infection?

1993 • 48 citations

Prognostic Value of Serum HIV-RNA Levels at Virologic Steady State After Seroconversion: Relation to CD4 Cell Count and Clinical Course of Primary Infection

1997 • 47 citations

Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals

1998 • 47 citations

Prognostic Value of Viremia in Patients with Long-Standing Human Immunodeficiency Virus Infection

1996 • 45 citations

When to Initiate Highly Active Antiretroviral Therapy: A Cohort Approach

2003 • 45 citations

Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: Adherence, side effects and efficacy

1999 • 42 citations

The cost-effectiveness of expanded HIV counselling and testing in primary care settings: a first look

2000 • 41 citations

Circumstances at HIV diagnosis and progression of disease in older HIV-infected Americans

2001 • 41 citations

Analysis of HIV-1 clinical trials: statistical magic?

1999 • 39 citations

Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men

1997 • 38 citations

Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection

1996 • 37 citations

Factors That Predict Incomplete Virological Response to Protease Inhibitor‐Based Antiretroviral Therapy

1999 • 37 citations

Coronary artery disease occurring with protease inhibitor therapy

1998 • 37 citations

Disease Progression, Adherence, and Response to Protease Inhibitor Therapy for HIV Infection in an Urban Veterans Affairs Medical Center

1999 • 36 citations

Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men

1998 • 35 citations

A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients

2000 • 33 citations

Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission

1994 • 32 citations

The SPICE Study: 48-Week Activity of Combinations of Saquinavir Soft Gelatin and Nelfinavir With and Without Nucleoside Analogues

2000 • 32 citations

The Cost-effectiveness of Voluntary Counseling and Testing of Hospital Inpatients for HIV Infection

1994 • 31 citations

Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed

1998 • 29 citations

Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals

1997 • 29 citations

Longitudinal Analysis of CD4 T Cell Counts, T Cell Reactivity, and Human Immunodeficiency Virus Type 1 RNA Levels in Persons Remaining AIDS‐Free despite CD4 Cell Counts < 200 for >5 Years

1997 • 29 citations

Decreased Medical Expenditures for Care of HIV-Seropositive Patients

1999 • 28 citations

The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count

1998 • 27 citations

Management of antiretroviral therapy for HIV infection: modelling when to change therapy.

1998 • 26 citations

Preventing Mycobacterium avium complex in patients who are using protease inhibitors

1998 • 25 citations

Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system

1990 • 25 citations

Course of Viral Load Throughout HIV-1 Infection

2000 • 25 citations

Management of Antiretroviral Therapy for HIV Infection: Modelling when to Change Therapy

1998 • 24 citations

Evaluation of a Hospital Admission HIV Antibody Voluntary Screening Program

1990 • 23 citations

Analytic Tools for Public Health Decision Making

2002 • 23 citations

Rapid Communication: Efavirenz- and Adefovir Dipivoxil–Based Salvage Therapy in Highly Treatment-Experienced Patients: Clinical and Genotypic Predictors of Virologic Response

2000 • 23 citations

The SPICE Study: 48-Week Activity of Combinations of Saquinavir Soft Gelatin and Nelfinavir With and Without Nucleoside Analogues

2000 • 23 citations

Routine Voluntary HIV Screening In STD Clinic Clients

1990 • 21 citations

Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T-cell count?

1998 • 18 citations

Mathematical Modeling of the Interrelationship of CD4 Lymphocyte Count and Viral Load Changes Induced by the Protease Inhibitor Indinavir

1998 • 18 citations

Who should be screened for HIV infection? A cost-effectiveness analysis

1993 • 16 citations

CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. A review for clinical practitioners

1994 • 16 citations

Clinical efficacy of protease inhibitor based antiretroviral combination therapy--a prospective cohort study.

1999 • 14 citations

Meta-analysis of Two Randomized Controlled Trials Comparing Combined Zidovudine and Didanosine Therapy With Combined Zidovudine, Didanosine, and Nevirapine Therapy in Patients With HIV

1999 • 13 citations

Cost-effectiveness of HIV screening in acute care settings

1996 • 9 citations

The sociodemographic profile, risk categories and prevalence of HIV infection among people attending a London same-day testing clinic, 2000–2001

2003 • 9 citations

High-Dose Saquinavir Plus Ritonavir: Long-Term Efficacy in HIV-Positive Protease Inhibitor–Experienced Patients and Predictors of Virologic Response

1999 • 6 citations

A state program for postpartum HIV counseling and testing.

1994 • 6 citations

Meta-analysis of Two Randomized Controlled Trials Comparing Combined Zidovudine and Didanosine Therapy With Combined Zidovudine, Didanosine, and Nevirapine Therapy in Patients With HIV

1999 • 5 citations

The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection

1994 • 3 citations